<DOC>
	<DOCNO>NCT01688050</DOCNO>
	<brief_summary>The TRANSFIX study clinical trial approve US FDA study safety effectiveness Zenith® TX2® Low Profile Endovascular Graft treatment Blunt Thoracic Aortic Injury .</brief_summary>
	<brief_title>TRANSFIX Zenith® Transection Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Thoracic Injuries</mesh_term>
	<mesh_term>Wounds , Nonpenetrating</mesh_term>
	<criteria>Vessels suitable endovascular access stent graft placement Blunt thoracic aortic injury descend thoracic aorta At least 16 year age Informed consent give patient legally authorize representative Clinical consideration would compromise patient safety study outcomes Unsuitable arterial anatomy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Blunt thoracic aortic injury</keyword>
	<keyword>Transection</keyword>
	<keyword>Endovascular graft</keyword>
</DOC>